News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
693,855 Results
Type
Article (41266)
Company Profile (224)
Press Release (652365)
Section
Business (209081)
Career Advice (2040)
Deals (36539)
Drug Delivery (85)
Drug Development (82431)
Employer Resources (170)
FDA (16311)
Job Trends (15302)
News (353482)
Policy (33753)
Tag
Academia (2568)
Africa (770)
Allergies (39)
Alliances (50850)
Alzheimer's disease (1111)
Antibody-drug conjugate (ADC) (49)
Approvals (16253)
Arizona (165)
Artificial intelligence (58)
Asia (39427)
Australia (6280)
Bankruptcy (360)
Best Places to Work (11302)
Biosimilars (58)
C2C Services and Suppliers (79727)
California (822)
Canada (645)
Cancer (181)
Career advice (1710)
CAR-T (34)
Cell therapy (67)
China (49)
Clinical research (64092)
Collaboration (58)
Colorado (34)
Compensation (30)
COVID-19 (2522)
Cystic fibrosis (71)
Diabetes (32)
Diagnostics (5968)
Diversity, equity & inclusion (44)
Drug pricing (53)
Earnings (84430)
Employer resources (144)
Europe (83677)
Events (109720)
FDA (16355)
Florida (106)
Funding (39)
Gene therapy (59)
GLP-1 (492)
Government (4385)
Healthcare (18704)
Hotbed/Location (489808)
Idaho (55)
Illinois (198)
Indiana (108)
Infectious disease (2535)
Inflammatory bowel disease (87)
Interviews (316)
IPO (16391)
Job creations (4042)
Job search strategy (1480)
Kansas (90)
Layoffs (391)
Legal (8275)
Liver cancer (52)
Lung cancer (37)
Maine (47)
Management (54)
Manufacturing (50)
Maryland (253)
Massachusetts (455)
Medical device (13027)
Medtech (13030)
Mergers & acquisitions (19838)
Metabolic disorders (161)
Neuroscience (1194)
New Jersey (62)
New York (83)
NextGen Class of 2024 (6569)
Non-profit (4488)
North Carolina (163)
Obesity (105)
Opinion (182)
Patents (35)
Peanut (35)
Pennsylvania (55)
People (57466)
Phase I (19785)
Phase II (28207)
Phase III (21217)
Podcasts (48)
Policy (37)
Postmarket research (2633)
Preclinical (8452)
Rare diseases (93)
Real estate (6226)
Recruiting (65)
Regulatory (21836)
Reports (32)
Research institute (2346)
Resumes & cover letters (352)
South America (1151)
Startups (3697)
Texas (88)
United States (3032)
Vaccines (425)
Washington State (114)
Weight loss (102)
Date
Today (45)
Last 7 days (499)
Last 30 days (1928)
Last 365 days (38850)
2024 (21948)
2023 (40628)
2022 (51797)
2021 (56332)
2020 (54795)
2019 (47401)
2018 (35772)
2017 (33139)
2016 (32662)
2015 (38617)
2014 (32516)
2013 (27631)
2012 (29729)
2011 (30487)
2010 (28497)
693,855 Results for "adarx pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
ADARx Pharmaceuticals, Inc. today announced the appointment of Chris Storgard, M.D., as Chief Medical Officer (CMO).
April 2, 2024
·
3 min read
Biotech Beach
ADARx Pharmaceuticals to Participate in the 44th Annual Cowen Healthcare Conference
ADARx Pharmaceuticals, Inc. today announced that Zhen Li, PhD, Co-Founder, President and CEO, will host one-on-one investor meetings at the 44th Annual Cowen Healthcare Conference on Monday, March 4, 2024 in Boston, Massachusetts.
February 21, 2024
·
1 min read
Biotech Beach
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference.
January 3, 2024
·
1 min read
Biotech Beach
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing.
August 9, 2023
·
3 min read
Biotech Beach
ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, today announced the close of a $46 million Series B-1 financing to advance its drug development pipeline as the Company’s first product enters the clinic.
January 20, 2023
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Drug Development
ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, today announced the dosing of the first cohort in a Phase 1 clinical study of ADX-324 for the treatment of hereditary angioedema (HAE).
January 20, 2023
·
2 min read
Business
ADARx Pharmaceuticals Expands Leadership Team, Appointing Robert MacLeod, Ph.D. as Chief Scientific Officer
ADARx Pharmaceuticals, Inc., a clinical stage biotechnology company developing RNA-targeting therapeutics, announced the expansion of their leadership team through the appointment of Robert MacLeod, Ph.D. as Chief Scientific Officer.
January 9, 2023
·
2 min read
Business
ADARx Pharmaceuticals Expands Leadership Team, Appointing Christopher Prentiss as CFO
ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA-targeting therapeutics, announced the expansion of their leadership team through the appointment of Christopher Prentiss as Chief Financial Officer.
September 28, 2022
·
2 min read
BioMidwest
Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy
Nika Pharmaceuticals, Inc. introduces its plans to develop the company into a sustainable business project that will consistently grow, bring good profits and provide dividends to its shareholders.
June 3, 2024
·
5 min read
1 of 69,386
Next